绿色空间暴露与老年人健康之间的关联:系统审查和元分析协议
Yajie Che1, Mengyao Wang1, Xinyun Tan2
1Xinjiang Medical University, School of Nursing, Urumqi, Xinjiang, China.
BMJ open
|October 1, 2025
概括
这次系统审查将评估绿色空间暴露如何影响老年人的健康. 调查结果将为城市规划和公共卫生战略提供信息,以应对人口老龄化.
科学领域:
- 环境健康 环境健康
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 城市化和人口老龄化的增加增加了空气污染的风险,特别是对老年人来说.
- 众所周知,绿地可以减轻空气污染对健康的影响.
- 现有的审查缺乏关于绿色空间对老年人健康的益处的综合数据.
研究的目的:
- 系统地审查和元分析绿色空间暴露对老年人的健康影响.
- 综合当前有关老年人绿地生理,心理和社会益处的证据.
主要方法:
- 遵守系统审查和元分析协议 (PRISMA-P) 准则的优先报告项目.
- 在电子数据库 (PubMed, Web of Science),NICE和指南国际网络中进行全面的文献搜索.
- 由两名研究人员进行独立选,数据提取和偏见风险评估;基于异质性的元分析或叙事综合.
主要成果:
- 该部分将在系统性审查和元分析完成后填写.
- 预期的结果将量化绿色空间暴露与老年人各种健康结果之间的关联.
结论:
- 这一系统审查将提供关于绿色空间对老年人的健康益处的关键证据.
- 结果将为城市规划,公共卫生政策和干预措施提供信息,以促进城市环境中的健康老龄化.
相关概念视频
Drug Dosing: Geriatric Patients
227
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
227
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
237
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
Dimensions of Health and Illness
10.5K
The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
10.5K


